Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Truist sale of Sterling Capital Management to Guardian Capital
We are advising Truist on the transaction
TKO Group Holdings $666 million secondary offering
The stock is listed on the New York Stock Exchange
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Ferrara Candy acquisition of Jelly Belly Candy
We are advising Ferrara on the acquisition
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Natera $250 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Upgrade $100 million acquisition of Uplift
We advised Upgrade on the transaction
Centogene strategic collaboration with Lifera
We are advising Centogene on its joint venture with and convertible debt investment by Lifera